Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0006632003
Mon, 05.02.2024
MorphoSys AG
Media Release
Planegg/Munich, Germany, February 5, 2024
MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value
Tafasitamab sold to Incyte
Novartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of
€ 68.00 per share in cash
Shareholders benefi [ … ]
Tue, 30.01.2024
MorphoSys AG
Media Release
Planegg/Munich, Germany, January 30, 2024
MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
Preliminary 2023 Monjuvi U.S. net product sales of US$ 92.0 million (€ 85.0 million) and preliminary gross margin for Monjuvi U.S. net prod [ … ]
Mon, 08.01.2024
MorphoSys AG
Media Release
Planegg/Munich, Germany, January 8, 2024
MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that Jean-Paul Kress, M.D., Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 3:00 p.m. [ … ]